fluoxetine has been researched along with Hypertension in 23 studies
Fluoxetine: The first highly specific serotonin uptake inhibitor. It is used as an antidepressant and often has a more acceptable side-effects profile than traditional antidepressants.
fluoxetine : A racemate comprising equimolar amounts of (R)- and (S)-fluoxetine. A selective serotonin reuptake inhibitor (SSRI), it is used (generally as the hydrochloride salt) for the treatment of depression (and the depressive phase of bipolar disorder), bullimia nervosa, and obsessive-compulsive disorder.
N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine : An aromatic ether consisting of 4-trifluoromethylphenol in which the hydrogen of the phenolic hydroxy group is replaced by a 3-(methylamino)-1-phenylpropyl group.
Hypertension: Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Our study aimed to evaluate the effect of fluoxetine on morning blood pressure surge (MBPS) in patients with ischemic stroke." | 8.02 | The effect of fluoxetine on morning blood pressure surge in patients with ischemic stroke: a prospective preliminary clinical study. ( Cai, Z; Deng, J; Guo, Y; He, Y; Zhang, H; Zhang, Y, 2021) |
| "A case of branch retinal vein occlusion associated with fluoxetine-induced secondary hypertension is described." | 7.74 | Branch retinal vein occlusion and fluoxetine. ( Knox Cartwright, NE; Smith, P; Tole, DM, 2007) |
| "In keeping with the anxiolytic property of selective serotonin reuptake inhibitors (SSRIs) in humans, we have examined in the spontaneously hypertensive rat (SHR) and the Wistar-Kyoto (WKY) rat, which display low and high anxiety, respectively, some psychoneuroendocrine effects of a repeated treatment with the SSRI fluoxetine (5 or 10 mg/kg daily, for 3 weeks)." | 7.70 | Effects of repeated fluoxetine on anxiety-related behaviours, central serotonergic systems, and the corticotropic axis axis in SHR and WKY rats. ( Aguerre, S; Berton, O; Chaouloff, F; Combourieu, I; Durand, M; Edno, L; Mormède, P, 1999) |
| "Our study aimed to evaluate the effect of fluoxetine on morning blood pressure surge (MBPS) in patients with ischemic stroke." | 4.02 | The effect of fluoxetine on morning blood pressure surge in patients with ischemic stroke: a prospective preliminary clinical study. ( Cai, Z; Deng, J; Guo, Y; He, Y; Zhang, H; Zhang, Y, 2021) |
| "A case of branch retinal vein occlusion associated with fluoxetine-induced secondary hypertension is described." | 3.74 | Branch retinal vein occlusion and fluoxetine. ( Knox Cartwright, NE; Smith, P; Tole, DM, 2007) |
| "In keeping with the anxiolytic property of selective serotonin reuptake inhibitors (SSRIs) in humans, we have examined in the spontaneously hypertensive rat (SHR) and the Wistar-Kyoto (WKY) rat, which display low and high anxiety, respectively, some psychoneuroendocrine effects of a repeated treatment with the SSRI fluoxetine (5 or 10 mg/kg daily, for 3 weeks)." | 3.70 | Effects of repeated fluoxetine on anxiety-related behaviours, central serotonergic systems, and the corticotropic axis axis in SHR and WKY rats. ( Aguerre, S; Berton, O; Chaouloff, F; Combourieu, I; Durand, M; Edno, L; Mormède, P, 1999) |
| "Outpatients with recurrent unipolar depression (DSM-IV criteria; N = 1096) were randomly assigned in a 3:1 ratio to 10 weeks of treatment with venlafaxine ER or fluoxetine." | 2.73 | The Prevention of Recurrent Episodes of Depression with Venlafaxine for Two Years (PREVENT) Study: Outcomes from the 2-year and combined maintenance phases. ( Ahmed, S; Dunner, DL; Ferguson, JM; Friedman, ES; Gelenberg, AJ; Hirschfeld, RM; Keller, MB; Kocsis, JH; Kornstein, SG; Musgnung, J; Nemeroff, CB; Ninan, PT; Pedersen, RD; Rothschild, AJ; Schatzberg, AF; Shelton, RC; Thase, ME; Trivedi, MH; Yan, B; Zajecka, JM, 2007) |
| "nortriptyline) was done." | 2.70 | Clinical and treatment response characteristics of late-life depression associated with vascular disease: a pooled analysis of two multicenter trials with sertraline. ( Clary, CM; Doraiswamy, PM; Krishnan, KR, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (8.70) | 18.7374 |
| 1990's | 9 (39.13) | 18.2507 |
| 2000's | 9 (39.13) | 29.6817 |
| 2010's | 1 (4.35) | 24.3611 |
| 2020's | 2 (8.70) | 2.80 |
| Authors | Studies |
|---|---|
| He, Y | 1 |
| Deng, J | 1 |
| Zhang, Y | 1 |
| Cai, Z | 1 |
| Zhang, H | 1 |
| Guo, Y | 1 |
| de Vries-Bouwstra, JK | 1 |
| Allanore, Y | 1 |
| Matucci-Cerinic, M | 1 |
| Balbir-Gurman, A | 1 |
| Kosiorek-Witek, A | 1 |
| Makulska-Nowak, HE | 1 |
| Applebee, GA | 1 |
| Attarian, HP | 1 |
| Schenck, CH | 1 |
| Akarachkova, ES | 1 |
| Tabeeva, GR | 1 |
| Volkova, ZI | 1 |
| Dlusskaia, IG | 1 |
| Striuk, RI | 1 |
| Veĭn, AM | 1 |
| Gillman, PK | 1 |
| Cai, XJ | 1 |
| Bi, XP | 1 |
| Zhao, Z | 1 |
| Wang, L | 1 |
| Keller, MB | 1 |
| Trivedi, MH | 1 |
| Thase, ME | 1 |
| Shelton, RC | 1 |
| Kornstein, SG | 2 |
| Nemeroff, CB | 1 |
| Friedman, ES | 1 |
| Gelenberg, AJ | 1 |
| Kocsis, JH | 1 |
| Dunner, DL | 1 |
| Hirschfeld, RM | 1 |
| Rothschild, AJ | 1 |
| Ferguson, JM | 1 |
| Schatzberg, AF | 1 |
| Zajecka, JM | 1 |
| Pedersen, RD | 1 |
| Yan, B | 1 |
| Ahmed, S | 1 |
| Musgnung, J | 1 |
| Ninan, PT | 1 |
| Knox Cartwright, NE | 1 |
| Smith, P | 1 |
| Tole, DM | 1 |
| Carlson, JA | 1 |
| Mazza, J | 1 |
| Kircher, K | 1 |
| Tran, TA | 1 |
| Sved, AF | 1 |
| Van Itallie, CM | 1 |
| Fernstrom, JD | 1 |
| Coulter, DM | 1 |
| Pillans, PI | 1 |
| Montastruc, JL | 1 |
| Chamontin, B | 1 |
| Senard, JM | 1 |
| Tran, MA | 1 |
| Rascol, O | 1 |
| Llau, ME | 1 |
| Rascol, A | 1 |
| Nyquist-Battie, C | 1 |
| Cochran, PK | 1 |
| Evans, VR | 1 |
| Hitchcock, JM | 1 |
| Unal, C | 1 |
| Azaz-Livshits, TL | 1 |
| Danenberg, HD | 1 |
| Amsterdam, JD | 1 |
| Garcia-Espana, F | 1 |
| Fawcett, J | 1 |
| Quitkin, FM | 1 |
| Reimherr, FW | 1 |
| Rosenbaum, JF | 1 |
| Beasley, C | 1 |
| Durand, M | 1 |
| Berton, O | 1 |
| Aguerre, S | 1 |
| Edno, L | 1 |
| Combourieu, I | 1 |
| Mormède, P | 1 |
| Chaouloff, F | 1 |
| Boylan, LS | 1 |
| Krishnan, KR | 1 |
| Doraiswamy, PM | 1 |
| Clary, CM | 1 |
| Fuller, RW | 1 |
| Holland, DR | 1 |
| Yen, TT | 1 |
| Bemis, KG | 1 |
| Stamm, NB | 1 |
| Suchowersky, O | 1 |
| deVries, JD | 1 |
| Hansen, TE | 1 |
| Dieter, K | 1 |
| Keepers, GA | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| An Acute and Continuation Phase Study of the Comparative Efficacy Study of Venlafaxine ER (Effexor® XR) and Fluoxetine (Prozac®) in Achieving and Sustaining Remission (Wellness) in Patients With Recurrent Unipolar Major Depression; Followed by a Long Term[NCT00046020] | Phase 4 | 1,096 participants (Actual) | Interventional | 2000-08-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for fluoxetine and Hypertension
| Article | Year |
|---|---|
Maintenance therapy to prevent recurrence of depression: summary and implications of the PREVENT study.
Topics: Adult; Antidepressive Agents, Second-Generation; Clinical Trials as Topic; Cyclohexanols; Delayed-Ac | 2008 |
4 trials available for fluoxetine and Hypertension
| Article | Year |
|---|---|
[The effects of antidepressant treatment on efficacy of antihypertensive therapy in elderly hypertension].
Topics: Aged; Antidepressive Agents; Antidepressive Agents, Second-Generation; Antihypertensive Agents; Bloo | 2006 |
The Prevention of Recurrent Episodes of Depression with Venlafaxine for Two Years (PREVENT) Study: Outcomes from the 2-year and combined maintenance phases.
Topics: Adult; Antidepressive Agents, Second-Generation; Cyclohexanols; Delayed-Action Preparations; Depress | 2007 |
Blood pressure changes during short-term fluoxetine treatment.
Topics: Adolescent; Adult; Aged; Antidepressive Agents, Second-Generation; Blood Pressure; Depression; Doubl | 1999 |
Clinical and treatment response characteristics of late-life depression associated with vascular disease: a pooled analysis of two multicenter trials with sertraline.
Topics: Age of Onset; Aged; Antidepressive Agents; Anxiety; Cardiovascular Diseases; Comorbidity; Depressive | 2001 |
18 other studies available for fluoxetine and Hypertension
| Article | Year |
|---|---|
The effect of fluoxetine on morning blood pressure surge in patients with ischemic stroke: a prospective preliminary clinical study.
Topics: Blood Pressure; Blood Pressure Monitoring, Ambulatory; Brain Ischemia; Circadian Rhythm; Fluoxetine; | 2021 |
Worldwide Expert Agreement on Updated Recommendations for the Treatment of Systemic Sclerosis.
Topics: Adrenal Cortex Hormones; Angiotensin-Converting Enzyme Inhibitors; Europe; Fluoxetine; Gastroesophag | 2020 |
Morphine Analgesia Modification in Normotensive and Hypertensive Female Rats after Repeated Fluoxetine Administration.
Topics: Animals; Dose-Response Relationship, Drug; Drug Interactions; Estrous Cycle; Female; Fluoxetine; Hyp | 2016 |
An angry bed partner.
Topics: Anger; Antidepressive Agents, Second-Generation; Bupropion; Coronary Artery Disease; Depressive Diso | 2009 |
[Clinical significance of adrenoreactivity in patients with some paroxysmal disorders (panic attacks and migraine)].
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Citalopram; Diagnostic and Statistical Manual of Men | 2003 |
Re: no evidence of increased adverse drug reactions in cytochrome P450 CYP2D6 poor metabolizers treated with fluoxetine or nortriptyline.
Topics: Antidepressive Agents; Cytochrome P-450 CYP2D6; Dose-Response Relationship, Drug; Fluoxetine; Humans | 2005 |
Branch retinal vein occlusion and fluoxetine.
Topics: Adult; Female; Fluoxetine; Fundus Oculi; Humans; Hypertension; Retinal Vein Occlusion; Selective Ser | 2007 |
Otophyma: a case report and review of the literature of lymphedema (elephantiasis) of the ear.
Topics: Adrenal Cortex Hormones; Alcoholism; Anti-Infective Agents; Anti-Inflammatory Agents; Antidepressive | 2008 |
Studies on the antihypertensive action of L-tryptophan.
Topics: Amino Acids; Animals; Antihypertensive Agents; Blood Pressure; Drug Interactions; Fenclonine; Fluoxe | 1982 |
Hypertension with moclobemide.
Topics: Adult; Aged; Antidepressive Agents; Benzamides; Cohort Studies; Drug Interactions; Female; Fluoxetin | 1995 |
Pseudophaeochromocytoma in parkinsonian patient treated with fluoxetine plus selegiline.
Topics: Adrenal Gland Neoplasms; Adult; Catecholamines; Diagnosis, Differential; Drug Interactions; Female; | 1993 |
Regulation of sympathetic presynaptic components in rat left ventricle during ligation of abdominal aorta.
Topics: Animals; Aorta, Abdominal; Binding Sites; Carrier Proteins; Fluoxetine; Hypertension; Ligation; Male | 1996 |
Tachycardia, orthostatic hypotension and profound weakness due to concomitant use of fluoxetine and nifedipine.
Topics: Aged; Aged, 80 and over; Antihypertensive Agents; Calcium Channel Blockers; Drug Interactions; Drug | 1997 |
Effects of repeated fluoxetine on anxiety-related behaviours, central serotonergic systems, and the corticotropic axis axis in SHR and WKY rats.
Topics: Animals; Anxiety; Basal Metabolism; Behavior, Animal; Drug Administration Schedule; Fluoxetine; Hipp | 1999 |
Mutual influences between paroxysmal hypertension and psychiatric disturbance.
Topics: Aged; Antidepressive Agents, Second-Generation; Autonomic Nervous System Diseases; Blood Pressure; D | 1999 |
Antihypertensive effects of fluoxetine and L-5-hydroxytryptophan in rats.
Topics: 5-Hydroxytryptophan; Animals; Antihypertensive Agents; Blood Pressure; Desoxycorticosterone; Drug In | 1979 |
Interaction of fluoxetine and selegiline.
Topics: Bipolar Disorder; Depressive Disorder; Drug Synergism; Drug Therapy, Combination; Female; Fluoxetine | 1990 |
Interaction of fluoxetine and pentazocine.
Topics: Adult; Anxiety; Ataxia; Drug Interactions; Fluoxetine; Humans; Hypertension; Male; Nausea; Paresthes | 1990 |